Երկիր: Ավստրալիա
Լեզու: անգլերեն
Աղբյուրը: Department of Health (Therapeutic Goods Administration)
methylphenidate hydrochloride, Quantity: 10 mg
Novartis Pharmaceuticals Australia Pty Ltd
Tablet, uncoated
Excipient Ingredients: calcium phosphate; magnesium stearate; Gelatin; purified talc; wheat starch; lactose monohydrate
Oral
100
(S8) Controlled Drug
Ritalin 10 tablets and Ritalin LA capsules are indicated for the treatment of ADHD. Ritalin 10 tablets are also indicated for the treatment of narcolepsy. Attention-Deficit Hyperactivity Disorder (ADHD) ADHD was previously known as attention-deficit disorder. Other terms used to describe this behavioural syndrome include: minimal brain dysfunction in children, hyperkinetic child syndrome, minimal brain damage, minimal cerebral dysfunction, minor cerebral dysfunction and psycho-organic syndrome of children. Ritalin 10 / Ritalin LA are indicatedas an integral part of a total treatment program for ADHD that may include other measures (psychological, educational and social) for patients with this syndrome. Stimulants are not intended for use in the patient who exhibits symptoms secondary to environmental factors and/or other primary psychiatric disorders, including psychosis. Special diagnostic considerations for ADHD in children: The aetiology of this syndrome is unknown and there is no single diagnostic test.
Visual Identification: Round white tablets marked CG on one side and AB with a break-line on the other, diameter ca. 7.1mmthickness ca. 2.6mm.; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius
Registered
1991-08-02
RITALIN ® 10 _methylphenidate hydrochloride_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Ritalin 10 tablets. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. The information in this leaflet was last updated on the date listed on the final page. More recent information on the medicine may be available. YOU SHOULD ENSURE THAT YOU SPEAK TO YOUR PHARMACIST OR DOCTOR TO OBTAIN THE MOST UP TO DATE INFORMATION ON THE MEDICINE. YOU CAN ALSO DOWNLOAD THE MOST UP TO DATE LEAFLET FROM WWW.NOVARTIS.COM.AU. Those updates may contain important information about the medicine and its use of which you should be aware. All medicines have risks and benefits. Your doctor has weighed the risks of you or your child taking this medicine against the benefits they expect it will provide. IF YOU HAVE ANY CONCERNS ABOUT THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT RITALIN 10 IS USED FOR Ritalin 10 tablets contain the active ingredient methylphenidate hydrochloride. Methylphenidate hydrochloride is a central nervous system stimulant. Ritalin 10 tablets have two uses. They are used to treat: • Attention Deficit Hyperactivity Disorder (ADHD); and • narcolepsy, a sleep-attack disorder. Your doctor may have prescribed it for another purpose. THIS MEDICINE SHOULD NOT BE USED TO PREVENT OR TREAT NORMAL FATIGUE. _ADHD_ About 3% of children suffer from ADHD. It makes them unable to sit still or concentrate on tasks for any length of time. They may have trouble learning and doing school work. They frequently become difficult to manage, both in school and at home. Ritalin 10 is thought to work by regulating specific chemicals in the brain that affect behaviour. It helps to focus attention, shut out distraction and allows impulsive people to think before they act. If successful, it will enhance an inattentive person's natural ability. This medicin Կարդացեք ամբողջական փաստաթուղթը
1 _ _ AUSTRALIAN PRODUCT INFORMATION RITALIN ® 10/RITALIN ® LA (METHYLPHENIDATE) _DRUG DEPENDENCE: Ritalin should be given cautiously to patients with a history of drug _ _dependence or alcoholism. Chronic abusive use can lead to marked _ _tolerance and _ _psychological dependence with varying degrees of abnormal behaviour. Frank psychotic _ _episodes can occur, especially with parenteral abuse. Careful supervision is required _ _during withdrawal from abusive use since severe depression may occur. Withdrawal _ _following chronic therapeutic use may unmask symptoms of the underlying disorder that _ _may require follow up. _ 1 NAME OF THE MEDICINE Methylphenidate hydrochloride. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Ritalin 10 contain methylphenidate hydrochloride 10 mg. Ritalin LA modified release capsules contain 10 mg, 20 mg, 30 mg, 40 mg or 60 mg of methylphenidate hydrochloride. Ritalin 10 contains lactose, sugars, milk products, lactitol, gluten and sulfur dioxide. Ritalin LA contains sucrose. For the full list of the excipients, see Section 6.1. 3 PHARMACEUTICAL FORM Ritalin 10 tablets are immediate release white tablets that are scored and marked AB and CG on the reverse. Ritalin LA are modified release capsules that presented as follows: 10 mg cotaining white to off-white beads in a light brown opaque hard gelatin capsule with the imprint of NVR on the cap and R10 on a white opaque body in tan-coloured ink. 20 mg containing white to off-white beads in a white opaque hard gelatin capsule with imprint NVR on the cap and R20 on body in tan-coloured ink. 30 mg containing white to off-white beads in a yellow opaque hard gelatin capsule with the imprint NVR on cap and R30 on body in tan-coloured ink. 40 mg containing white to off-white beads in a light brown opaque hard gelatin capsule with the imprint NVR on cap and R40 on body in tan-coloured ink. 60 mg containing white to off-white beads in a light brown opaque cap and a yellow opaque body hard gelatin capsule with imprint NVR on cap and R60 on body in Կարդացեք ամբողջական փաստաթուղթը